Opportunity Information: Apply for PAR 21 357
The Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required), listed as PAR-21-357, is a National Institutes of Health (NIH) discretionary grant opportunity designed to strengthen research capacity at institutions that historically receive relatively low levels of NIH funding. The program focuses on supporting small-scale biomedical and health-related research projects while simultaneously building a stronger research environment on campus. A central goal is to create meaningful, hands-on research experiences for students, with particular emphasis on health professional students as well as undergraduate and graduate trainees. In practice, the award is meant to help institutions expand research opportunities, improve mentorship and training in research settings, and reinforce a culture where student involvement in biomedical research is a core part of the institution's educational mission.
This specific R15 announcement is labeled "Clinical Trial Required," which signals that the proposed work is expected to include a clinical trial component as defined by NIH policy. Applicants should treat that designation as a major design constraint: the project should be structured in a way that aligns with NIH expectations for clinical trial planning, oversight, and reporting. Because of that, proposals typically need clear clinical endpoints or outcomes, appropriate human subjects protections, feasible recruitment and retention plans, and the operational infrastructure to run a compliant trial, even at a smaller scale. The clinical trial requirement also implies careful attention to data and safety monitoring and other compliance elements that come with NIH-supported clinical research.
Eligible applicants include U.S.-based public or state-controlled institutions of higher education and private institutions of higher education, along with other qualifying organizations that meet the program's eligibility expectations. The opportunity explicitly highlights that a range of designated serving institutions may apply, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). At the same time, it clearly limits foreign participation: non-domestic (non-U.S.) entities are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply. However, "foreign components" are allowed when they meet the NIH Grants Policy Statement definition, meaning a U.S. applicant may include certain foreign elements in the research if they are justified and compliant with NIH policy, even though the prime applicant must be domestic.
From a funding standpoint, the posted award ceiling is $300,000, reinforcing the program's small-scale, capacity-building intent rather than large, multi-site or resource-intensive efforts. The opportunity is associated with multiple CFDA numbers (including 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.307, 93.361, 93.393, 93.394, 93.395, 93.399, 93.837, 93.838, 93.839, 93.840, 93.853, 93.865, 93.866, and 93.867), reflecting that NIH may issue awards for a broad range of health and biomedical research areas under different institutes and centers. The opportunity record shows a creation date of January 10, 2022, and lists an original closing date of January 7, 2025, which is the key deadline applicants would use for planning submission timelines unless updated deadlines apply through NIH systems.
Overall, REAP (R15) under PAR-21-357 is best understood as an institutional enhancement mechanism: it funds a defined research project that includes a clinical trial, but it is equally aimed at developing people and infrastructure at less NIH-intensive institutions. Competitive projects are typically those that are scientifically solid and feasible within a modest budget, embed students meaningfully in the research work, and leave the institution stronger in terms of research experience, mentorship, and readiness for future externally funded research.Apply for PAR 21 357
- The National Institutes of Health in the education, health, income security and social services sector is offering a public funding opportunity titled "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.307, 93.361, 93.393, 93.394, 93.395, 93.399, 93.837, 93.838, 93.839, 93.840, 93.853, 93.865, 93.866, 93.867.
- This funding opportunity was created on 2022-01-10.
- Applicants must submit their applications by 2025-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- Eligible applicants include: Public and State controlled institutions of higher education, Private institutions of higher education, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIH Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) - PAR-21-357
What is PAR-21-357 (REAP R15 Clinical Trial Required)?
PAR-21-357 is a National Institutes of Health (NIH) discretionary grant opportunity under the Research Enhancement Award Program (REAP). It is an R15 mechanism aimed at strengthening research capacity at institutions that historically receive relatively low levels of NIH funding by supporting small-scale biomedical and health-related research projects.
What is the main purpose of the REAP (R15) program described here?
The program is designed to build a stronger campus research environment while funding a defined research project. A core emphasis is expanding hands-on research experiences for students, improving research mentorship and training, and reinforcing a campus culture where student participation in biomedical research is a central part of the educational mission.
Who is this opportunity intended to benefit within an institution?
It is intended to create meaningful, hands-on research experiences for students, with particular emphasis on health professional students as well as undergraduate and graduate trainees, while also strengthening mentorship and research training on campus.
Does this R15 opportunity require a clinical trial?
Yes. This specific announcement is labeled "Clinical Trial Required," meaning the proposed work is expected to include a clinical trial component as defined by NIH policy.
What does "Clinical Trial Required" mean for project design?
It functions as a major design constraint. The project should be structured to align with NIH expectations for clinical trial planning, oversight, and reporting, even if the effort is relatively small in scale.
What clinical trial elements are implied by the opportunity description?
Based on the information provided, proposals typically need clear clinical endpoints or outcomes, appropriate human subjects protections, feasible recruitment and retention plans, and operational infrastructure to run a compliant trial. The requirement also implies attention to data and safety monitoring and other compliance elements tied to NIH-supported clinical research.
What types of institutions are eligible to apply?
Eligible applicants include U.S.-based public or state-controlled institutions of higher education and private institutions of higher education, along with other qualifying organizations that meet the program's eligibility expectations.
Are specific types of serving institutions highlighted as eligible?
Yes. The opportunity explicitly highlights a range of designated serving institutions, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).
Can a non-U.S. (foreign) organization apply as the main applicant?
No. Non-domestic (non-U.S.) entities are not eligible to apply as the prime applicant.
Can a U.S. organization submit an application that includes a non-U.S. component?
Non-domestic components of U.S. organizations are not eligible to apply. However, the opportunity indicates that "foreign components" are allowed when they meet the NIH Grants Policy Statement definition, meaning a U.S. applicant may include certain foreign elements in the research if they are justified and compliant with NIH policy.
What is the maximum award amount (funding ceiling) listed for this opportunity?
The posted award ceiling is $300,000, consistent with the program's small-scale, capacity-building intent.
Is this funding intended for large, resource-intensive clinical trials?
No. The description frames this as a small-scale award intended to strengthen institutional research capacity rather than support large, multi-site, or resource-intensive efforts.
What kinds of research areas can be supported under PAR-21-357?
The opportunity is associated with multiple CFDA numbers, reflecting that NIH may issue awards for a broad range of health and biomedical research areas under different NIH institutes and centers.
Which CFDA numbers are associated with this opportunity?
The listing includes CFDA numbers 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.307, 93.361, 93.393, 93.394, 93.395, 93.399, 93.837, 93.838, 93.839, 93.840, 93.853, 93.865, 93.866, and 93.867.
When was this opportunity record created?
The opportunity record shows a creation date of January 10, 2022.
What deadline is shown for PAR-21-357 in the information provided?
The record lists an original closing date of January 7, 2025. The description notes this is the key deadline applicants would use for planning submission timelines unless updated deadlines apply through NIH systems.
What kinds of projects are likely to be competitive based on the description provided?
Competitive projects are typically described as scientifically solid and feasible within a modest budget, designed to embed students meaningfully in the research work, and structured to leave the institution stronger in research experience, mentorship, and readiness for future externally funded research.
What is the overall intent of REAP (R15) under PAR-21-357 beyond the research project itself?
It is framed as an institutional enhancement mechanism: it funds a defined research project that includes a clinical trial, while also aiming to develop people and infrastructure at less NIH-intensive institutions and expand student-centered research training and mentorship.
Browse more opportunities from the same category: Education, Health, Income Security and Social Services
Next opportunity: Chemical and Materials Sciences to Advance Clean Energy Technologies and Low-Carbon Manufacturing
Previous opportunity: Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 21 357
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 21 357) also looked into and applied for these:
| Funding Opportunity |
|---|
| HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required) Apply for RFA NS 22 037 Funding Number: RFA NS 22 037 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) Apply for RFA MH 22 145 Funding Number: RFA MH 22 145 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed) Apply for RFA DE 22 011 Funding Number: RFA DE 22 011 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Emergency Award HEAL Initiative: Developing and Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) Apply for RFA MH 22 176 Funding Number: RFA MH 22 176 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $500,000 |
| Emergency Award HEAL Initiative: Optimizing Existing Evidence-Based Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) Apply for RFA MH 22 175 Funding Number: RFA MH 22 175 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $12,500,000 |
| BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) Apply for RFA MH 22 115 Funding Number: RFA MH 22 115 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required) Apply for RFA NR 22 002 Funding Number: RFA NR 22 002 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional) Apply for RFA NR 22 003 Funding Number: RFA NR 22 003 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $275,000 |
| HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed) Apply for RFA NS 22 021 Funding Number: RFA NS 22 021 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) Apply for RFA NS 22 050 Funding Number: RFA NS 22 050 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) Apply for RFA NS 22 026 Funding Number: RFA NS 22 026 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed) Apply for RFA NS 22 027 Funding Number: RFA NS 22 027 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $225,000 |
| BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Mouse Brain (UM1 Clinical Trial Not Allowed) Apply for RFA NS 22 048 Funding Number: RFA NS 22 048 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) Apply for RFA NS 22 049 Funding Number: RFA NS 22 049 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Human and Non-Human Primate Brain (UM1 Clinical Trial Not Allowed) Apply for RFA NS 22 047 Funding Number: RFA NS 22 047 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional) Apply for RFA NS 22 028 Funding Number: RFA NS 22 028 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Coordinating Center to Support Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (U24 Clinical Trial Not Allowed) Apply for PAR 22 120 Funding Number: PAR 22 120 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $1,500,000 |
| Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (UG3/UH3 Clinical Trial Optional) Apply for PAR 22 115 Funding Number: PAR 22 115 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) Apply for RFA MH 22 220 Funding Number: RFA MH 22 220 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) Apply for RFA OD 22 010 Funding Number: RFA OD 22 010 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 357", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.